Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Prepaid Assets (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Prepaid Assets for 16 consecutive years, with $985000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets rose 71.01% to $985000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $985000.0, a 71.01% increase, with the full-year FY2024 number at $1.1 million, down 15.47% from a year prior.
  • Prepaid Assets was $985000.0 for Q3 2025 at Plus Therapeutics, down from $1.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $3.7 million in Q4 2022 to a low of $487000.0 in Q3 2023.
  • A 5-year average of $1.0 million and a median of $885500.0 in 2022 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: skyrocketed 81.31% in 2021, then tumbled 65.38% in 2023.
  • Plus Therapeutics' Prepaid Assets stood at $817000.0 in 2021, then soared by 352.51% to $3.7 million in 2022, then crashed by 65.38% to $1.3 million in 2023, then fell by 15.47% to $1.1 million in 2024, then decreased by 8.96% to $985000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Prepaid Assets are $985000.0 (Q3 2025), $1.1 million (Q4 2024), and $576000.0 (Q3 2024).